US Patent 11446389 Maytansinoid derivatives, conjugates thereof, and methods of use
Patent 11446389 was granted and assigned to Regeneron Pharmaceuticals on September, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11446389 Maytansinoid derivatives, conjugates thereof, and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
